A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials

The Hippo pathway is involved in colorectal cancer (CRC) development and progression. The Hippo regulator Rassf1a is also involved in the Ras signaling cascade. In this work, we tested single nucleotide polymorphisms within Hippo components and their association with outcome in CRC patients treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Sebio, A., Stintzing, S., Heinemann, V., Sunakawa, Y., Zhang, W., Ichikawa, W., Tsuji, A., Takahashi, T., Parek, A., Yang, D., Cao, S., Ning, Y., Stremitzer, S., Matsusaka, S., Okazaki, S., Barzi, A., Berger, M., Lenz, H-J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378677/
https://www.ncbi.nlm.nih.gov/pubmed/27698403
http://dx.doi.org/10.1038/tpj.2016.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378677/
https://www.ncbi.nlm.nih.gov/pubmed/27698403
http://dx.doi.org/10.1038/tpj.2016.69

Ejemplares similares